Combination vs monotherapy for management of myelofibrosis

Talha Badar posted on X:

“Interesting debate on combination vs monotherapy for management of myelofibrosis.

Efficacy vs tolerability vs disease modification.

Dr. Adam Mead and Dr. Florian Heidel.”

Source: Talha Badar/X

Dr. Talha Badar, MD, is a specialist in Hematology Oncology based in Mayo Clinic, Jacksonville, Florida. His primary areas of expertise include Leukemia, particularly Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplantation. Over his career, he has actively contributed to clinical research and clinical trials.